MedPath
HSA Approval

NAPA 250 SUPPOSITORY 250 mg

SIN10522P

NAPA 250 SUPPOSITORY 250 mg

NAPA 250 SUPPOSITORY 250 mg

December 8, 1998

PHARMATECH MEDICAL ENTERPRISE PTE LTD

PHARMATECH MEDICAL ENTERPRISE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMATECH MEDICAL ENTERPRISE PTE LTD
Licence HolderPHARMATECH MEDICAL ENTERPRISE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

SUPPOSITORY

RECTAL

Medical Information

N02BE01

paracetamol

Manufacturer Information

PHARMATECH MEDICAL ENTERPRISE PTE. LTD.

BEXIMCO PHARMACEUTICALS LTD

Active Ingredients

PARACETAMOL

250 mg

Acetaminophen

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

NAPA 250 SUPPOSITORY 250 mg - HSA Approval | MedPath